Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma

Metallothionein-3 has poorly characterized functions in neuroblastoma. Cisplatin-based chemotherapy is a major regimen to treat neuroblastoma, but its clinical efficacy is limited by chemoresistance. We investigated the impact of human metallothionein-3 (hMT3) up-regulation in neuroblastoma cells an...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Sci Rep
Main Authors: Rodrigo, Miguel Angel Merlos, Michalkova, Hana, Strmiska, Vladislav, Casar, Berta, Crespo, Piero, de los Rios, Vivian, Ignacio Casal, J., Haddad, Yazan, Guran, Roman, Eckschlager, Tomas, Pokorna, Petra, Heger, Zbynek, Adam, Vojtech
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2021
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7943580/
https://ncbi.nlm.nih.gov/pubmed/33750814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-84185-x
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki